SCHEMBL6998583

SCHEMBL6998583

N[C@@H]1CC1c1cccc(F)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 2/20 0.61
HTR2A P28223 1/20 0.61
HTR2B P41595 1/20 0.61
KDM1A O60341 14/20 0.60
MAOB P27338 9/20 0.56
MAOA P21397 7/20 0.56
CYP2C19 P33261 4/20 0.56
CYP2B6 P20813 3/20 0.56
KCNH2 Q12809 3/20 0.56
CYP1A2 P05177 2/20 0.56
CYP2D6 P10635 2/20 0.56
CYP2C9 P11712 2/20 0.56
LMNA P02545 2/20 0.56
TAAR1 Q96RJ0 2/20 0.56
CYP3A4 P08684 1/20 0.56
HTR1A P08908 1/20 0.56
ADRA2A P08913 1/20 0.56
CYP2A6 P11509 1/20 0.56
SLC6A2 P23975 1/20 0.56
ADRA1A P35348 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3031647 1.00 HTR2C (0.61) HTR2CHTR2AHTR2BKDM1AMAOB
SCHEMBL3419759 1.00 HTR2C (0.61) HTR2CHTR2AHTR2BKDM1AMAOB
SCHEMBL3422301 1.00 HTR2C (0.61) HTR2CHTR2AHTR2BKDM1AMAOB
Trifluoroacetic Acid SCHEMBL3045297 0.85 KDM1A (0.51) HTR2CHTR2AHTR2BKDM1AMAOB
SCHEMBL1645762 0.81 HTR2A (0.50) HTR2CHTR2AHTR2BKDM1ALMNA
SCHEMBL1645763 0.81 HTR2A (0.50) HTR2CHTR2AHTR2BKDM1ALMNA
SCHEMBL1645497 0.81 HTR2A (0.50) HTR2CHTR2AHTR2BKDM1AMAOB
SCHEMBL4253057 0.81 HTR2A (0.50) HTR2CHTR2AHTR2BKDM1AMAOB
SCHEMBL12498168 0.80 HTR2C (0.49) HTR2CHTR2AHTR2BKDM1AMAOB
SCHEMBL13272292 0.79 HTR2A (0.56) HTR2CHTR2AHTR2BKDM1AMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0996621-B1 TRIAZOLO[4,5-d]PYRIMIDINE DERIVATIVES AS ANTI-THROMBOTIC AGENTS ASTRAZENECA AB (SE) 2003-10-01 EP disclosed
US-6251910-B1 1,2,3-triazolo[4,5-d]pyrimidines as P2T receptor antagonists ASTRAZENECA UK LIMITED (GB) 2001-06-26 US disclosed